Skip to content
Screener

Emergent Biosolutions EBS MCM Products — Total depreciation

Other segment segments

All other segment
$800K

Similar metrics at other companies

Leonardo DRS, Inc. logo
DRSASC — Total depreciation
$13M+8.3%
Leonardo DRS, Inc. logo
DRSIMS — Total depreciation
$6M0.0%
The E.W. Scripps Company logo
SSPOther — Total depreciation
$89K+71.2%
Perrigo Company logo
PRGOInfant Formula — Total depreciation
$19.5M+132%
Perrigo Company logo
PRGOSelf Care — Total depreciation
$13.5M-12.3%
Perrigo Company logo
PRGOSpecialty Care — Total depreciation
$4.3M+10.3%

Other financials

Income statement

See full
Revenue$234.3M+66.3%
Gross profit$137.2M+85.4%
Operating income-$125.1M-7,919%
Net income-$180.2M-1,402%
EPS (diluted)-$3.49-1,486%

Balance sheet

See full
Cash & equivalents$140.9M-48.0%
Total debt$588.2M-13.0%
Total equity$341.4M-36.3%
Total assets$1.1B-21.2%

Cash flow

See full
Operating cash flow$56.1M-47.3%
CapEx$2.1M-27.6%
Free cash flow$54.0M-47.8%

Valuation

See full
Market cap$229.19M-47.4%
Enterprise value$676.49M-19.5%
P/S0.3×-0.2×

Profitability

See full
Gross margin55.9%+2.4pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin11.9%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.7×+0.5×
Current ratio5.4×-0.2×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001367644-26-000082
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Depreciation from reportable segments:
MCM Products$4.3$4.9$8.8$9.1
Items not included in depreciation from reportable segments:
All other segment0.60.41.12.6
Other1.92.03.94.7
Total depreciation$6.8$7.3$13.8$16.4

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Emergent Biosolutions's MCM products — total depreciation?
Emergent Biosolutions (EBS) reported MCM products — total depreciation of $4.3M in Q2 2026.
How has Emergent Biosolutions's MCM products — total depreciation changed year-over-year?
Emergent Biosolutions's MCM products — total depreciation decreased by 12.2% year-over-year, from $4.9M to $4.3M.
What is the long-term trend for Emergent Biosolutions's MCM products — total depreciation?
Over 4 years (2021 to 2025), Emergent Biosolutions's MCM products — total depreciation has grown at a -7.5% compound annual growth rate (CAGR), from $24.7M to $18.1M.
What does MCM products — total depreciation mean?
This reflects the systematic allocation of the cost of tangible assets used by the MCM segment over their useful lives. It is a key non-cash expense that impacts the segment's reported profitability and reflects the intensity of capital asset utilization.

Ask your AI about Emergent Biosolutions's mcm products — total depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude